Cargando…
Development of New Genome Editing Tools for the Treatment of Hyperlipidemia
Hyperlipidemia is a medical condition characterized by high levels of lipids in the blood. It is often associated with an increased risk of cardiovascular diseases such as heart attacks and strokes. Traditional treatment approaches for hyperlipidemia involve lifestyle modifications, dietary changes,...
Autor principal: | Preta, Giulio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605581/ https://www.ncbi.nlm.nih.gov/pubmed/37887310 http://dx.doi.org/10.3390/cells12202466 |
Ejemplares similares
-
Monoclonal Antibodies, Gene Silencing and Gene Editing (CRISPR) Therapies for the Treatment of Hyperlipidemia—The Future Is Here
por: Hermel, Melody, et al.
Publicado: (2023) -
Genome Editing Tools in Plants
por: Mohanta, Tapan Kumar, et al.
Publicado: (2017) -
Monogenic hyperlipidemias
por: Krasi, Geraldo, et al.
Publicado: (2019) -
Genome Editing in Medicine: Tools and Challenges
por: Petraitytė, Gunda, et al.
Publicado: (2021) -
New tools for experimental diabetes research: Cellular reprogramming and genome editing
por: Otonkoski, Timo
Publicado: (2016)